- Home
- LTBR vs ARCT Comparison
LTBR vs ARCT Comparison
Compare LTBR & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTBR
- ARCT
- Stock Information
- Founded
- LTBR 1992
- ARCT 2013
- Country
- LTBR United States
- ARCT United States
- Employees
- LTBR N/A
- ARCT N/A
- Industry
- LTBR Professional Services
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- LTBR Consumer Discretionary
- ARCT Health Care
- Exchange
- LTBR Nasdaq
- ARCT Nasdaq
- Market Cap
- LTBR 326.6M
- ARCT 320.8M
- IPO Year
- LTBR N/A
- ARCT N/A
- Fundamental
- Price
- LTBR $16.17
- ARCT $19.48
- Analyst Decision
- LTBR
- ARCT Strong Buy
- Analyst Count
- LTBR 0
- ARCT 8
- Target Price
- LTBR N/A
- ARCT $48.83
- AVG Volume (30 Days)
- LTBR 1.5M
- ARCT 648.4K
- Earning Date
- LTBR 08-11-2025
- ARCT 08-11-2025
- Dividend Yield
- LTBR N/A
- ARCT N/A
- EPS Growth
- LTBR N/A
- ARCT N/A
- EPS
- LTBR N/A
- ARCT N/A
- Revenue
- LTBR N/A
- ARCT $122,122,000.00
- Revenue This Year
- LTBR N/A
- ARCT N/A
- Revenue Next Year
- LTBR N/A
- ARCT $37.73
- P/E Ratio
- LTBR N/A
- ARCT N/A
- Revenue Growth
- LTBR N/A
- ARCT N/A
- 52 Week Low
- LTBR $2.24
- ARCT $8.04
- 52 Week High
- LTBR $18.80
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- LTBR 59.61
- ARCT 75.39
- Support Level
- LTBR $13.42
- ARCT $11.27
- Resistance Level
- LTBR $18.80
- ARCT $19.99
- Average True Range (ATR)
- LTBR 1.47
- ARCT 1.31
- MACD
- LTBR 0.25
- ARCT 0.79
- Stochastic Oscillator
- LTBR 58.12
- ARCT 94.15
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.